Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel produc...
Novavax Inc (NVAX) has a valuation score of 60/100 (moderate), profitability score of 50/100 (moderate), financial health score of 78/100 (strong), Piotroski F-Score of 5/9, Altman Z-Score of -4.71 (distressed), revenue growth of -17.2% YoY.
Neutral
Analyst Consensus
BuyWall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026
Analyst Recommendations15 analysts · 2026-08-01
4
6
2
2
Strong Buy 4Buy 6Hold 2Sell 2Strong Sell 1
Recent Market Moves
See all NVAX moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Aug 25 | Regular | $9.44 | +6.55% | 4.36 |
| Aug 25 | After-hours | $9.44 | +6.55% | 4.36 |
| Aug 19 | Pre-market | $8.29 | +4.52% | 3.01 |
| Aug 7 | Regular | $7.97 | +3.04% | 2.02 |
| Aug 4 | Regular | $7.66 | +3.37% | 2.25 |